Compare · HWH vs MCK
HWH vs MCK
Side-by-side comparison of HWH International Inc. (HWH) and McKesson Corporation (MCK): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both HWH and MCK operate in Other Pharmaceuticals (Health Care), so they compete in similar markets.
- MCK is the larger of the two at $101.43B, about 12679.5x HWH ($8.0M).
- Over the past year, HWH is down 1.3% and MCK is up 18.5% - MCK leads by 19.9 points.
- MCK has hit the wire 4 times in the past 4 weeks while HWH has been quiet.
- MCK has more recent analyst coverage (25 ratings vs 0 for HWH).
- Company
- HWH International Inc.
- McKesson Corporation
- Price
- $1.13+11.39%
- $828.02-0.90%
- Market cap
- $8.0M
- $101.43B
- 1M return
- -14.77%
- -5.81%
- 1Y return
- -1.32%
- +18.54%
- Industry
- Other Pharmaceuticals
- Other Pharmaceuticals
- Exchange
- NASDAQ
- NYSE
- IPO
- 2022
- News (4w)
- 0
- 4
- Recent ratings
- 0
- 25
McKesson Corporation
McKesson Corporation provides healthcare supply chain management, retail pharmacy, community oncology and specialty care, and healthcare information solutions in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The International segment offers distribution and services to wholesale, institutional, and retail customers in 13 European countries and Canada. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The RxTS segment offers CoverMyMeds solution to help patients get the medications; RelayHealth, a workflow solution; RxCrossroads solution for therapies and interventions to biopharma manufacturers; and McKesson Prescription Automation, a customized pharmacy automation technology; and Multi-Client Central Fill as a Service, a pharmacy. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
Latest HWH
- SEC Form 4 filed by Chan Heng Fai Ambrose
- Amendment: SEC Form SCHEDULE 13D/A filed by HWH International Inc.
- SEC Form 10-K filed by HWH International Inc.
- SEC Form 4 filed by Chan Heng Fai Ambrose
- SEC Form DEFM14C filed by HWH International Inc.
- SEC Form 144 filed by HWH International Inc.
- HWH International Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Financial Statements and Exhibits
- SEC Form 4 filed by Large owner Chan Heng Fai Ambrose
- Amendment: SEC Form SCHEDULE 13D/A filed by HWH International Inc.
- Chief Executive Officer Chan Heng Fai Ambrose was granted 1,000,000 shares, increasing direct ownership by 38,462% to 1,002,600 units (SEC Form 4)
Latest MCK
- McKesson Corporation Declares Quarterly Dividend
- McKesson Signs Agreement with Apollo Funds for Strategic Minority Interest in Medical-Surgical Solutions
- SEC Form 3 filed by new insider Fraga Francisco
- McKesson Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits
- Amendment: SEC Form SCHEDULE 13G/A filed by McKesson Corporation
- McKesson Corporation filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
- McKesson Corporation Announces Fourth Quarter Fiscal 2026 Earnings Release Date and Participation in Upcoming Conferences
- McKesson Corporation filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
- McKesson Announces Planned CFO Transition
- EVP and Chief Legal Officer Lau Michele sold $2,697,750 worth of shares (2,725 units at $990.00), decreasing direct ownership by 46% to 3,247 units (SEC Form 4)